On April 24, 2023 Agenus (NASDAQ: AGEN), a leading immuno-oncology company specializing in immunological agents for cancer and infectious diseases, reported that Dr. Garo Armen, Chairman and CEO, will participate in the following upcoming investor conferences (Press release, Agenus, APR 24, 2023, View Source [SID1234630449]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

HC Wainwright BioConnect Investor Conference – Fireside chat presentation will be held in-person at NASDAQ Headquarters in New York City on Tuesday, May 2nd, 2023 at 3:30 PM ET

EF Hutton Global Conference – 1×1 meetings will be held in-person at the Plaza Hotel in New York City on Wednesday, May 10th, 2023

A live webcast of the fireside chat from the HC Wainwright BioConnect Investor Conference can be accessed on the company’s website at View Source A replay will be posted following the event.